Sichuan Kelun Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000PW7
CNY
34.10
0.09 (0.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
21,536.19
21,151.20
18,787.01
17,053.58
16,265.45
17,411.33
16,122.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
21,536.19
21,151.20
18,787.01
17,053.58
16,265.45
17,411.33
16,122.58
Raw Material Cost
10,791.73
10,449.42
9,307.33
7,902.19
7,737.05
7,208.45
6,738.72
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
154.68
370.71
482.21
532.53
576.64
608.94
632.60
Selling and Distribution Expenses
4,802.03
5,529.25
5,586.98
6,069.97
5,832.09
7,455.42
6,812.83
Other Expenses
186.92
143.75
117.84
110.08
85.98
61.15
24.13
Total Expenditure (Excl Depreciation)
17,617.60
17,786.86
16,554.94
15,605.47
15,005.56
15,884.31
14,425.48
Operating Profit (PBDIT) excl Other Income
3918.6000000000004
3364.3
2232.1
1448.1
1259.8999999999999
1527
1697.1000000000001
Other Income
301.18
359.40
164.87
256.00
239.31
224.55
264.86
Operating Profit (PBDIT)
5,442.49
4,897.06
3,550.94
2,884.52
2,612.27
2,777.02
2,950.95
Interest
154.68
370.71
482.21
532.53
576.64
608.94
632.60
Exceptional Items
-24.51
-39.27
-31.00
-76.09
-6.70
-10.76
-142.64
Gross Profit (PBDT)
10,744.46
10,701.78
9,479.69
9,151.39
8,528.40
10,202.88
9,383.86
Depreciation
1,298.41
1,258.76
1,198.00
1,225.58
1,160.73
1,075.07
988.98
Profit Before Tax
3,964.89
3,228.32
1,839.73
1,050.31
868.20
1,082.25
1,186.72
Tax
923.40
933.79
363.70
309.50
163.55
234.75
65.92
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,935.89
2,456.11
1,705.32
1,102.55
829.39
937.86
1,212.94
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,935.89
2,456.11
1,705.32
1,102.55
829.39
937.86
1,212.94
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
426.06
190.53
-1.10
-234.44
-37.91
83.69
54.54
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,361.95
2,646.64
1,704.22
868.12
791.48
1,021.54
1,267.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
0.0
Reserves
22,479.52
19,672.38
15,734.31
13,856.83
13,499.18
13,188.05
12,747.14
Earnings per share (EPS)
1.86
1.59
1.15
0.78
0.58
0.66
0.0
Diluted Earnings per share
1.86
1.59
1.15
0.78
0.58
0.66
0.0
Operating Profit Margin (Excl OI)
17.84%
15.5%
11.65%
8.23%
7.45%
8.49%
10.53%
Gross Profit Margin
24.44%
21.21%
16.17%
13.35%
12.47%
12.39%
13.49%
PAT Margin
13.63%
11.61%
9.08%
6.47%
5.1%
5.39%
7.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 1.82% vs 12.58% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 27.03% vs 55.30% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 13.30% vs 34.01% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -58.27% vs -23.12% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Sichuan Kelun Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
21,536.19
0
21,536.19
Other Operating Income
0.00
0.00
0.00
Total Operating income
21,536.19
0
21,536.19
Raw Material Cost
10,791.73
0
10,791.73
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
154.68
0
154.68
Selling and Distribution Expenses
4,802.03
0
4,802.03
Other Expenses
186.92
0.00
186.92
Total Expenditure (Excl Depreciation)
17,617.60
0
17,617.60
Operating Profit (PBDIT) excl Other Income
3,918.59
0.00
3,918.59
Other Income
301.18
0
301.18
Operating Profit (PBDIT)
5,442.49
0
5,442.49
Interest
154.68
0
154.68
Exceptional Items
-24.51
0
-24.51
Gross Profit (PBDT)
10,744.46
0
10,744.46
Depreciation
1,298.41
0
1,298.41
Profit Before Tax
3,964.89
0
3,964.89
Tax
923.40
0
923.40
Provisions and contingencies
0
0
0.00
Profit After Tax
2,935.89
0
2,935.89
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,935.89
0
2,935.89
Share in Profit of Associates
0
0
0.00
Minority Interest
426.06
0
426.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,361.95
0
3,361.95
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
22,479.52
0
22,479.52
Earnings per share (EPS)
1.86
0
1.86
Diluted Earnings per share
1.86
0
1.86
Operating Profit Margin (Excl OI)
17.84%
0%
0.00
17.84%
Gross Profit Margin
24.44%
0%
0.00
24.44%
PAT Margin
13.63%
0%
0.00
13.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,153.62 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1.82% vs 12.58% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 336.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 27.03% vs 55.30% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 514.13 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 13.30% vs 34.01% in Dec 2023

Annual - Interest
Interest 15.47 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -58.27% vs -23.12% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.84%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023